Abstract:Background: Cancer remains one of the leading causes of mortality globally, with conventional chemotherapy often resulting in severe side effects and limited effectiveness. Recent advancements in bioinformatics and machine learning, particularly deep learning, offer promising new avenues for cancer treatment through the prediction and identification of anticancer peptides. Objective: This study aimed to develop and evaluate a deep learning model utilizing a two-dimensional convolutional neural network (2D CNN) to enhance the prediction accuracy of anticancer peptides, addressing the complexities and limitations of current prediction methods. Methods: A diverse dataset of peptide sequences with annotated anticancer activity labels was compiled from various public databases and experimental studies. The sequences were preprocessed and encoded using one-hot encoding and additional physicochemical properties. The 2D CNN model was trained and optimized using this dataset, with performance evaluated through metrics such as accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC-ROC). Results: The proposed 2D CNN model achieved superior performance compared to existing methods, with an accuracy of 0.87, precision of 0.85, recall of 0.89, F1-score of 0.87, and an AUC-ROC value of 0.91. These results indicate the model's effectiveness in accurately predicting anticancer peptides and capturing intricate spatial patterns within peptide sequences. Conclusion: The findings demonstrate the potential of deep learning, specifically 2D CNNs, in advancing the prediction of anticancer peptides. The proposed model significantly improves prediction accuracy, offering a valuable tool for identifying effective peptide candidates for cancer treatment. Future work: Further research should focus on expanding the dataset, exploring alternative deep learning architectures, and validating the model's predictions through experimental studies. Efforts should also aim at optimizing computational efficiency and translating these predictions into clinical applications.

Pep-CNN: an Improved Convolutional Neural Network for Predicting Therapeutic Peptides

PepCNN deep learning tool for predicting peptide binding residues in proteins using sequence, structural, and language model features

Efficient prediction of anticancer peptides through deep learning

PepNet: an interpretable neural network for anti-inflammatory and antimicrobial peptides prediction using a pre-trained protein language model

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

PepFormer: End-to-End Transformer-Based Siamese Network to Predict and Enhance Peptide Detectability Based on Sequence Only

CAMP: a Convolutional Attention-based Neural Network for Multifaceted Peptide-protein Interaction Prediction

ITP-Pred: an interpretable method for predicting, therapeutic peptides with fused features low-dimension representation

PepMNet: A Hybrid Deep Learning Model for Predicting Peptide Properties Using Hierarchical Graph Representations

Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

Deep Learning-Based Bioactive Therapeutic Peptide Generation and Screening

Enhancing Drug Peptide Sequence Prediction Using Multi-view Feature Fusion Learning

Ranking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction

CACPP: A Contrastive Learning-Based Siamese Network to Identify Anticancer Peptides Based on Sequence Only.

PepGB: Facilitating peptide drug discovery via graph neural networks

TP-LMMSG: a Peptide Prediction Graph Neural Network Incorporating Flexible Amino Acid Property Representation.

DeepTPpred: A Deep Learning Approach with Matrix Factorization for Predicting Therapeutic Peptides by Integrating Length Information

NeuroCNN_GNB: an Ensemble Model to Predict Neuropeptides Based on a Convolution Neural Network and Gaussian Naive Bayes.

A deep attention model for wide-genome protein-peptide binding affinity prediction at a sequence level

Deep2Pep: A Deep Learning Method in Multi-label Classification of Bioactive Peptide